ATON SA (ALTAO) - Financial and Strategic SWOT Analysis Review
Description
ATON SA (ALTAO) - Financial and Strategic SWOT Analysis Review
- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
ATON SA (ATON), formerly Hybrigenics SA, is advancing medical discoveries by supporting bioscience companies with innovative platforms and technologies. The company offers ethically sourced clinical tissues for research and preclinical and clinical services through Inoviem Scientific. ATON provides advanced monoclonal antibodies for in vitro diagnostic tests through Bcell Design, assisting manufacturers in achieving regulatory compliance. It produces equipment for analyzing molecular interactions through PIMS Technology, while Stemcis specializes in sterile, single-use surgical kits for fat transfer surgeries, enhancing efficiency and patient safety in medical procedures. ATON is headquartered in Illkirch-Graffenstaden, France.
ATON SA Key Recent Developments
Sep 26,2023: Hybrigenics Re-Brands to ‘Aton’ as Company Signals New Global Vision and Strategy to Advance Breakthrough Treatments
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
33 Pages
- Section 1 - About the Company
- ATON SA - Key Facts
- ATON SA - Key Employees
- ATON SA - Major Products and Services
- ATON SA - History
- ATON SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- ATON SA - Business Description
- ATON SA - Corporate Strategy
- ATON SA - SWOT Analysis
- SWOT Analysis - Overview
- ATON SA - Strengths
- ATON SA - Weaknesses
- ATON SA - Opportunities
- ATON SA - Threats
- ATON SA - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- ATON SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- ATON SA, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- ATON SA, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Sep 26, 2023: Hybrigenics Re-Brands to ‘Aton’ as Company Signals New Global Vision and Strategy to Advance Breakthrough Treatments
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- ATON SA, Key Facts
- ATON SA, Key Employees
- ATON SA, Major Products and Services
- ATON SA, History
- ATON SA, Subsidiaries
- ATON SA, Key Competitors
- ATON SA, Ratios based on current share price
- ATON SA, Annual Ratios
- ATON SA, Annual Ratios (Cont...1)
- ATON SA, Interim Ratios
- ATON SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- ATON SA, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- ATON SA, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- ATON SA, Performance Chart (2019 - 2023)
- ATON SA, Ratio Charts
- ATON SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- ATON SA, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
